LPL Financial’s Trinity Biotech TRIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.15K Buy
15,036
+2,351
+19% +$1.73K ﹤0.01% 5934
2025
Q4
$10K Buy
+12,685
New +$12.5K ﹤0.01% 5849
2023
Q1
Sell
-5,200
Closed -$25.7K 4587
2022
Q4
$25.7K Sell
5,200
-3,420
-40% -$20.7K ﹤0.01% 4341
2022
Q3
$46K Sell
8,620
-1,130
-12% -$7.29K ﹤0.01% 4243
2022
Q2
$60K Sell
9,750
-10,585
-52% -$64.6K ﹤0.01% 4214
2022
Q1
$108K Sell
20,335
-1,060
-5% -$6.11K ﹤0.01% 3962
2021
Q4
$153K Buy
21,395
+3,580
+20% +$33.8K ﹤0.01% 4052
2021
Q3
$192K Buy
17,815
+5,800
+48% +$68K ﹤0.01% 4001
2021
Q2
$177K Buy
12,015
+7,590
+172% +$126K ﹤0.01% 3940
2021
Q1
$83K Buy
+4,425
New +$106K ﹤0.01% 3950
2015
Q2
Sell
-3,658
Closed -$352K 2944
2015
Q1
$352K Buy
+3,658
New +$338K ﹤0.01% 2116
2014
Q3
Sell
-6,566
Closed -$756K 2782
2014
Q2
$756K Buy
+6,566
New +$778K ﹤0.01% 1517
2014
Q1
Sell
-2,231
Closed -$280K 2720
2013
Q4
$280K Sell
2,231
-630
-22% -$75.6K ﹤0.01% 2173
2013
Q3
$322K Sell
2,861
-210
-7% -$20.5K ﹤0.01% 1962
2013
Q2
$259K Buy
+3,071
New +$255K ﹤0.01% 2011

Other funds holding TRIB

LPL Financial's TRIB Position: Q1 2026 in Review

LPL Financial increased its Trinity Biotech (TRIB) stake by 19% in Q1 2026, buying an estimated $1.73K and bringing the position to 15,036 shares worth $8.15K. The position accounts for ﹤0.01% of the portfolio, ranked #5934.

LPL Financial first reported a position in TRIB in Q2 2013 and has held it in 15 quarters since. The position peaked at $756K in Q2 2014. 23 funds tracked by Wall St. Rank hold TRIB as of Q1 2026.

  • LPL Financial held 15,036 shares of Trinity Biotech worth $8.15K as of Q1 2026.
  • LPL Financial bought 2,351 Trinity Biotech shares in Q1 2026, an estimated $1.73K.
  • Trinity Biotech made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5934 holding.
  • LPL Financial first reported a position in Trinity Biotech in Q2 2013 and has held it in 15 quarters since.
  • LPL Financial's Trinity Biotech position peaked at $756K in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Trinity Biotech as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.